Related Experiment Video
Updated: Sep 3, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.8K
MLP-PSO Hybrid Algorithm for Heart Disease Prediction
Ali Al Bataineh1, Sarah Manacek2
1Department of Electrical and Computer Engineering, Norwich University, Barre, VT 05663, USA.
Journal of Personalized Medicine
|July 27, 2022
Summary
Machine learning (ML) models can predict heart disease risk. A new hybrid ML approach, MLP-PSO, achieved 84.61% accuracy, enabling earlier and more effective cardiovascular disease diagnosis.
Area of Science:
- Cardiology
- Medical Informatics
- Machine Learning
Background:
- Machine learning (ML) is increasingly vital in healthcare for enhancing diagnostic accuracy and timeliness.
- Predicting and preventing cardiovascular disease (CVD) is a critical area in clinical data analysis due to rising treatment costs.
- Manual assessment of heart disease risk is challenging due to numerous contributing factors.
Purpose of the Study:
- To develop and compare ML algorithms for predicting heart disease using the Cleveland Heart Disease dataset.
- To introduce and evaluate an alternative multilayer perceptron (MLP) training technique using particle swarm optimization (PSO) for heart disease detection.
Main Methods:
- The study employed a proposed MLP-PSO hybrid algorithm alongside ten other ML algorithms.
- Performance evaluation was conducted using various classification metrics.
Main Results:
- The proposed MLP-PSO hybrid algorithm demonstrated superior performance compared to all other tested algorithms.
- The MLP-PSO model achieved an accuracy of 84.61% in predicting heart disease.
Conclusions:
- The developed MLP-PSO classifier facilitates earlier, more accurate, and effective diagnosis of heart disease.
- This ML-based approach empowers healthcare providers with better tools for cardiovascular disease management.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
43
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30

